Advertisement
Canada markets open in 7 hours 34 minutes
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7257
    -0.0006 (-0.08%)
     
  • CRUDE OIL

    84.33
    +1.60 (+1.93%)
     
  • Bitcoin CAD

    85,583.77
    +980.48 (+1.16%)
     
  • CMC Crypto 200

    1,278.83
    +393.29 (+42.84%)
     
  • GOLD FUTURES

    2,395.10
    -2.90 (-0.12%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,375.75
    -171.50 (-0.98%)
     
  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    37,133.21
    -946.49 (-2.49%)
     
  • CAD/EUR

    0.6823
    +0.0002 (+0.03%)
     

Company News For Oct 11, 2017

Steel Dynamics (STLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
  • Shares Barracuda Networks, Inc. CUDA gained 0.04% after posting second quarter 2018 revenues of $94 million, surpassing the Zacks Consensus Estimate of $93 million

  • Merck & Co., Inc.’s MRK shares gained 0.2% after the company purchased a 9.9% stake in KalVista Pharmaceuticals Inc. KALV at a price of $8.50 per share

  • AnaptysBio, Inc.’s ANAB shares rallied 101.2% after the company announced positive results and proof-of-concept data from Phase 2a trial of it drug ANB020 In used for the treatment atopic dermatitis

  • Shares of Hudson Technologies Inc. HDSN declined 0.8% after the company lowered its third quarter 2017 earnings guidance to $0.03-$0.05 a share from $0.10 per share earlier


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Barracuda Networks, Inc. (CUDA) : Free Stock Analysis Report
 
Merck & Company, Inc. (MRK) : Free Stock Analysis Report
 
Hudson Technologies, Inc. (HDSN) : Free Stock Analysis Report
 
AnaptysBio, Inc. (ANAB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research